Develops a catheter-based denervation device for pulmonary hypertension / heart failure.
| Date | Round | Amount |
|---|---|---|
| Sep 2023 | Series A France-based Gradient Denervation Technologies raised a EUR14M Series A led by Asabys Partners, with Thuja Capital and Sofinnova. | $15.1M |